ClinicalTrials.Veeva

Menu

Evaluation of Lung Atelectasis During Apneic Oxygenation Using THRIVE in Adults During Laryngeal Surgery. (A-THRIVE)

K

Karolinska University Hospital

Status

Completed

Conditions

Anesthesia

Treatments

Device: THRIVE
Device: Endotracheal intubation

Study type

Interventional

Funder types

Other

Identifiers

NCT03458091
A-THRIVE

Details and patient eligibility

About

Oxygenation with high-flow nasal cannula with 100% oxygen have now been evaluated in a number of studies and the data are convincing. The THRIVE technique is able to oxygenate patients safely and vital parameters has been shown to be stable. But it is of great importance to evaluate this new concept regarding other potential negative physiological aspects such as lung atelectasis and inflammatory stress response before implementing it into clinical practice.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults, >18 years old.
  2. ENT-surgery where apnea is of benefit for the surgeon (eg. intraoral or laryngeal surgery).
  3. Capable of understanding the study information and sign the written consent.

Exclusion criteria

  1. ASA>2
  2. NYHA >2
  3. Pacemaker or ICD.
  4. BMI >35
  5. Pregnancy
  6. Manifest cardiac failure or coronary disease
  7. Severe gastrointestinal reflux.
  8. Neuromuscular disorder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Intubation
Active Comparator group
Description:
The patients will be intubated and ventilated
Treatment:
Device: Endotracheal intubation
THRIVE
Experimental group
Description:
The patients will be oxygenated during apnea using THRIVE
Treatment:
Device: THRIVE

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems